US75915K3095 - Common Stock
REGULUS THERAPEUTICS INC
NASDAQ:RGLS (5/3/2024, 7:15:34 PM)
After market: 2.62 -0.03 (-1.13%)2.65
-0.04 (-1.49%)
Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. The company is headquartered in San Diego, California and currently employs 29 full-time employees. The company went IPO on 2012-10-04. The firm is leveraging its oligonucleotide drug discovery and development to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. The Company’s lead product candidate includes RGLS8429. The firm is developing single-stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are complementary to (thereby pairing with) the target microRNA. RGLS8429 is an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD). RGLS8429 maintains beneficial attributes, such as preferential kidney exposure and similar PK profile, miR-17 inhibition potency and duration of action in the kidney, equal potency in vitro and in vivo efficacy studies.
REGULUS THERAPEUTICS INC
Suite 210, 3545 John Hopkins Court
San Diego CALIFORNIA 92121
P: 18582026300
CEO: Joseph P. Hagan
Employees: 29
Website: https://www.regulusrx.com/
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Regulus Therapeutics (NASDAQ:RGLS) just reported results for the fourth quarter...
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday!
Here you can normally see the latest stock twits on RGLS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: